About the Relapsed Leukemia and Lymphoma Program
The Cancer Center at Children's Hospital of Philadelphia (CHOP) offers a unique treatment program for children with relapsed, refractory or resistant-to-front-line-therapy leukemia and lymphoma. The program is staffed by a world-class team of pediatric oncologists who specialize in cases of leukemia and lymphoma that return after initial treatment with standard protocols.
Responding to relapse
When leukemia or lymphoma doesn’t respond to treatment, or relapses after therapy, it may be more difficult to handle than other cancers. It's now time to consider treatments that are designed specifically for children whose cancer has returned. At this point, it is important that your child be evaluated by an oncologist with special expertise in relapsed leukemia and lymphoma.
Experimental therapy for pediatric cancer
At the Cancer Center at CHOP, our experts have unparalleled experience treating children who have suffered a relapse. Their experience has prepared them to evaluate your child's case quickly, consider all the available options, and make recommendations about the best path for your family.